-
2
-
-
37549048643
-
The management of patients with uterine sarcoma: A debated clinical challenge
-
Gadducci A, Cosio S, Romanini A, et al. The management of patients with uterine sarcoma: a debated clinical challenge. Crit Rev Oncol Hematol. 2008;65:129-142.
-
(2008)
Crit Rev Oncol Hematol.
, vol.65
, pp. 129-142
-
-
Gadducci, A.1
Cosio, S.2
Romanini, A.3
-
3
-
-
0018122732
-
Uterine sarcomas: Natural history, treatment and prognosis
-
Salazar OM, Bonfiglio TA, Patten SF, et al. Uterine sarcomas: natural history, treatment and prognosis. Cancer. 1978;42:1152-1160.
-
(1978)
Cancer
, vol.42
, pp. 1152-1160
-
-
Salazar, O.M.1
Bonfiglio, T.A.2
Patten, S.F.3
-
4
-
-
52049118515
-
Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: A SEER analysis
-
Nemani D, Mitra N, Guo M, et al. Assessing the effects of lymphadenectomy and radiation therapy in patients with uterine carcinosarcoma: a SEER analysis. Gynecol Oncol. 2008;111:82-88.
-
(2008)
Gynecol Oncol.
, vol.111
, pp. 82-88
-
-
Nemani, D.1
Mitra, N.2
Guo, M.3
-
5
-
-
0031260023
-
Carcinosarcoma of the uterus: A clinicopathological multicenter CTF study
-
Sartori E, Bazzurini L, Gadducci A, et al. Carcinosarcoma of the uterus: a clinicopathological multicenter CTF study. Gynecol Oncol. 1997;67:70-75.
-
(1997)
Gynecol Oncol.
, vol.67
, pp. 70-75
-
-
Sartori, E.1
Bazzurini, L.2
Gadducci, A.3
-
6
-
-
75749084357
-
The impact of multi-modal therapy on survival for uterine carcinosarcomas
-
Bosquet JG, Terstriep SA, Cliby WA, et al. The impact of multi-modal therapy on survival for uterine carcinosarcomas. Gynecol Oncol. 2010;116:419-423.
-
(2010)
Gynecol Oncol.
, vol.116
, pp. 419-423
-
-
Bosquet, J.G.1
Terstriep, S.A.2
Cliby, W.A.3
-
7
-
-
0031127636
-
Uterine carcinosarcomas: Incidence and trends in management and survival
-
Arrastia CD, Fruchter RG, Clark M, et al. Uterine carcinosarcomas: incidence and trends in management and survival. Gynecol Oncol. 1997;65:158-163.
-
(1997)
Gynecol Oncol.
, vol.65
, pp. 158-163
-
-
Arrastia, C.D.1
Fruchter, R.G.2
Clark, M.3
-
8
-
-
0035169864
-
Prognostic parameters in carcinosarcomas of the uterus: A clinico-pathologic study
-
Bodner-Adler B, Bodner K, Obermair A, et al. Prognostic parameters in carcinosarcomas of the uterus: a clinico-pathologic study. Anticancer Res. 2001;21:3069-3074.
-
(2001)
Anticancer Res.
, vol.21
, pp. 3069-3074
-
-
Bodner-Adler, B.1
Bodner, K.2
Obermair, A.3
-
9
-
-
0036326732
-
Analysis of clinicopathologic factors in malignant mixed mullerian tumors of the uterine corpus
-
Inthasorn P, Carter J, Valmadre S, et al. Analysis of clinicopathologic factors in malignant mixed mullerian tumors of the uterine corpus. Int J Gynecol Cancer. 2002;12:348-353.
-
(2002)
Int J Gynecol Cancer
, vol.12
, pp. 348-353
-
-
Inthasorn, P.1
Carter, J.2
Valmadre, S.3
-
10
-
-
79955550125
-
Revised FIGO staging system for endometrial cancer
-
Lewin SN. Revised FIGO Staging System for endometrial cancer. Clin Obstet Gynecol. 2011;54:215-218.
-
(2011)
Clin Obstet Gynecol.
, vol.54
, pp. 215-218
-
-
Lewin, S.N.1
-
11
-
-
81155123086
-
The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma
-
Tanner EJ, Leitao MM Jr, Garg K, et al. The role of cytoreductive surgery for newly diagnosed advanced-stage uterine carcinosarcoma. Gynecol Oncol. 2011;123:548-552.
-
(2011)
Gynecol Oncol.
, vol.123
, pp. 548-552
-
-
Tanner, E.J.1
Leitao, M.M.2
Garg, K.3
-
12
-
-
41849100978
-
Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: An European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874)
-
Reed NS, Mangioni C, Malmström H, et al. Phase III randomised study to evaluate the role of adjuvant pelvic radiotherapy in the treatment of uterine sarcomas stages I and II: an European Organisation for Research and Treatment of Cancer Gynaecological Cancer Group Study (protocol 55874). Eur J Cancer. 2008;44:808-818.
-
(2008)
Eur J Cancer
, vol.44
, pp. 808-818
-
-
Reed, N.S.1
Mangioni, C.2
Malmström, H.3
-
13
-
-
0022006615
-
A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: A Gynaecologic Oncology Group Study
-
Omura GA, Blessing JA, Major F, et al. A randomized clinical trial of adjuvant adriamycin in uterine sarcomas: a Gynaecologic Oncology Group Study. J Clin Oncol. 1985;3:1240-1245.
-
(1985)
J Clin Oncol.
, vol.3
, pp. 1240-1245
-
-
Omura, G.A.1
Blessing, J.A.2
Major, F.3
-
14
-
-
84865687098
-
A multi-institutional cohort study of adjuvant therapy in stage IYII uterine carcinosarcoma
-
Cantrell LA, Havrilesky L, Moore DT, et al. A multi-institutional cohort study of adjuvant therapy in stage IYII uterine carcinosarcoma. Gynecol Oncol. 2012;127:22-26.
-
(2012)
Gynecol Oncol.
, vol.127
, pp. 22-26
-
-
Cantrell, L.A.1
Havrilesky, L.2
Moore, D.T.3
-
15
-
-
35348917431
-
A gynecologic oncology group randomized phase III trial of whole abdominal irradiation (WAI) vs. Cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage IYIV carcinosarcoma (CS) of the uterus
-
Wolfson AH, Brady MF, Rocereto T, et al. A Gynecologic Oncology Group randomized phase III trial of whole abdominal irradiation (WAI) vs. cisplatin-ifosfamide and mesna (CIM) as post-surgical therapy in stage IYIV carcinosarcoma (CS) of the uterus. Gynecol Oncol. 2007;107:177-185.
-
(2007)
Gynecol Oncol.
, vol.107
, pp. 177-185
-
-
Wolfson, A.H.1
Brady, M.F.2
Rocereto, T.3
-
16
-
-
37349058160
-
Carboplatin plus paclitaxel for advanced or recurrent uterine malignant mixed mullerian tumors. The British Columbia Cancer Agency experience
-
Hoskins PJ, Le N, Ellard S, et al. Carboplatin plus paclitaxel for advanced or recurrent uterine malignant mixed mullerian tumors. The British Columbia Cancer Agency experience. Gynecol Oncol. 2008;108:58-62.
-
(2008)
Gynecol Oncol.
, vol.108
, pp. 58-62
-
-
Hoskins, P.J.1
Le, N.2
Ellard, S.3
-
17
-
-
84880367975
-
Impact of treatment strategies on local control and survival in uterine carcinosarcomas in Turkey
-
Kucukoztas N, Dizdar O, Rahatli S, et al. Impact of treatment strategies on local control and survival in uterine carcinosarcomas in Turkey. Asian Pac J Cancer Prev. 2013;14:2959-2962.
-
(2013)
Asian Pac J Cancer Prev.
, vol.14
, pp. 2959-2962
-
-
Kucukoztas, N.1
Dizdar, O.2
Rahatli, S.3
-
18
-
-
33745058649
-
Combined adjuvant cisplatin and ifosfamide chemotherapy and radiotherapy for malignant mixed mullerian tumors of the uterus
-
Wong L, See HT, Khoo-Tan HS, et al. Combined adjuvant cisplatin and ifosfamide chemotherapy and radiotherapy for malignant mixed mullerian tumors of the uterus. Int J Gynecol Cancer. 2006;16:1364-1369.
-
(2006)
Int J Gynecol Cancer
, vol.16
, pp. 1364-1369
-
-
Wong, L.1
See, H.T.2
Khoo-Tan, H.S.3
-
19
-
-
84875944999
-
A population-based series of uterine carcinosarcomas with long-term follow-up
-
Sorbe B, Paulsson G, Andersson S, et al. A population-based series of uterine carcinosarcomas with long-term follow-up. Acta Oncol. 2013;52:759-766.
-
(2013)
Acta Oncol.
, vol.52
, pp. 759-766
-
-
Sorbe, B.1
Paulsson, G.2
Andersson, S.3
-
20
-
-
61849158753
-
Evaluation of prognostic factors and treatment outcomes in uterine carcinosarcoma
-
Galaal K, Kew FM, Tam KF, et al. Evaluation of prognostic factors and treatment outcomes in uterine carcinosarcoma. Eur J Obstet Gynecol Reprod Biol. 2009;143:88-92.
-
(2009)
Eur J Obstet Gynecol Reprod Biol.
, vol.143
, pp. 88-92
-
-
Galaal, K.1
Kew, F.M.2
Tam, K.F.3
-
21
-
-
48549106142
-
Uterine carcinosarcomas and grade 3 endometrioid cancers: Evidence for distinct tumor behavior
-
Bansal N, Herzog TJ, Seshan VE, et al. Uterine carcinosarcomas and grade 3 endometrioid cancers: evidence for distinct tumor behavior. Obstet Gynecol. 2008;112:64-70.
-
(2008)
Obstet Gynecol.
, vol.112
, pp. 64-70
-
-
Bansal, N.1
Herzog, T.J.2
Seshan, V.E.3
-
22
-
-
0031455206
-
An evaluation of prognostic factors in uterine carcinosarcoma
-
Nordal RR, Kristensen GB, Stenwig AE, et al. An evaluation of prognostic factors in uterine carcinosarcoma. Gynecol Oncol. 1997;67:316-321.
-
(1997)
Gynecol Oncol.
, vol.67
, pp. 316-321
-
-
Nordal, R.R.1
Kristensen, G.B.2
Stenwig, A.E.3
-
23
-
-
69449098378
-
Patterns of failure for conservatively managed surgical stage I uterine carcinosarcoma: Implications for adjuvant therapy
-
Leath CA 3rd, Numnum TM, Kendrick JE 4th, et al. Patterns of failure for conservatively managed surgical stage I uterine carcinosarcoma: implications for adjuvant therapy. Int J Gynecol Cancer. 2009;19:888-891.
-
(2009)
Int J Gynecol Cancer
, vol.19
, pp. 888-891
-
-
Leath, C.A.1
Numnum, T.M.2
Kendrick, J.E.3
-
24
-
-
0038637704
-
Surgery for uterine sarcoma: Review of the literature and recommendations for the standard surgical procedure
-
Morice P, Rodrigues A, Pautier P, et al. Surgery for uterine sarcoma: review of the literature and recommendations for the standard surgical procedure. Gynecol Obstet Fertil. 2003;31:147-150.
-
(2003)
Gynecol Obstet Fertil.
, vol.31
, pp. 147-150
-
-
Morice, P.1
Rodrigues, A.2
Pautier, P.3
-
25
-
-
0027402723
-
Prognostic factors in early-stage uterine sarcoma: A Gynecologic Oncology Group study
-
Major FJ, Blessing JA, Silverberg SG, et al. Prognostic factors in early-stage uterine sarcoma: a Gynecologic Oncology Group study. Cancer. 1993;71:1702-1709.
-
(1993)
Cancer
, vol.71
, pp. 1702-1709
-
-
Major, F.J.1
Blessing, J.A.2
Silverberg, S.G.3
-
26
-
-
0032211276
-
Results of postoperative radiotherapy in the treatment of sarcoma of the corpus uteri
-
Knocke TH, Kucera H, Dorfler D, et al. Results of postoperative radiotherapy in the treatment of sarcoma of the corpus uteri. Cancer. 1998;83:1972-1979.
-
(1998)
Cancer
, vol.83
, pp. 1972-1979
-
-
Knocke, T.H.1
Kucera, H.2
Dorfler, D.3
-
27
-
-
0033048439
-
Impact of radiotherapy on local control and survival in uterine sarcomas: A retrospective study from the Group Oncologic Catala-Occita
-
Ferrer F, Sabater S, Farrús B, et al. Impact of radiotherapy on local control and survival in uterine sarcomas: a retrospective study from the Group Oncologic Catala-Occita. Int J Radiat Oncol Biol Phys. 1999;44:47-52.
-
(1999)
Int J Radiat Oncol Biol Phys.
, vol.44
, pp. 47-52
-
-
Ferrer, F.1
Sabater, S.2
Farrús, B.3
-
28
-
-
0031172699
-
The role of whole-pelvic irradiation in the treatment of early-stage uterine carcinosarcomas
-
Chi DS, Mychalczak B, Saigo PE, et al. The role of whole-pelvic irradiation in the treatment of early-stage uterine carcinosarcomas. Gynecol Oncol. 1997;65:493-498.
-
(1997)
Gynecol Oncol.
, vol.65
, pp. 493-498
-
-
Chi, D.S.1
Mychalczak, B.2
Saigo, P.E.3
-
29
-
-
33947491518
-
Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: A Gynecologic Oncology Group Study
-
Homesley HD, Filiaci V, Markman M, et al. Phase III trial of ifosfamide with or without paclitaxel in advanced uterine carcinosarcoma: a Gynecologic Oncology Group Study. J Clin Oncol. 2007;25:526-531.
-
(2007)
J Clin Oncol.
, vol.25
, pp. 526-531
-
-
Homesley, H.D.1
Filiaci, V.2
Markman, M.3
-
30
-
-
77954948152
-
Phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: A Gynecologic Oncology Group study
-
Powell MA, Filiaci VL, Rose PG, et al. Phase II evaluation of paclitaxel and carboplatin in the treatment of carcinosarcoma of the uterus: a Gynecologic Oncology Group study. J Clin Oncol. 2010;28:2727-2731.
-
(2010)
J Clin Oncol.
, vol.28
, pp. 2727-2731
-
-
Powell, M.A.1
Filiaci, V.L.2
Rose, P.G.3
-
31
-
-
55649083105
-
A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage IYIV uterine carcinosarcoma
-
Makker V, Abu-Rustum NR, Alektiar KM, et al. A retrospective assessment of outcomes of chemotherapy-based versus radiation-only adjuvant treatment for completely resected stage IYIV uterine carcinosarcoma. Gynecol Oncol. 2008;111:249-254.
-
(2008)
Gynecol Oncol.
, vol.111
, pp. 249-254
-
-
Makker, V.1
Abu-Rustum, N.R.2
Alektiar, K.M.3
|